Factors associated with abrupt discontinuation of dabigatran therapy in patients with atrial fibrillation in Malaysia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Factors associated with abrupt discontinuation of dabigatran therapy in patients with atrial fibrillation in Malaysia
Authors
Keywords
Atrial fibrillation, Dabigatran, Discontinuation, Malaysia, DOAC, Stroke prevention
Journal
International Journal of Clinical Pharmacy
Volume 38, Issue 5, Pages 1182-1190
Publisher
Springer Nature
Online
2016-07-23
DOI
10.1007/s11096-016-0350-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Site-Level Variation in and Practices Associated With Dabigatran Adherence
- (2015) Supriya Shore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
- (2014) Craig T. January et al. CIRCULATION
- Management of dyspepsia symptoms on dabigatran during RELY-ABLE: long-term follow up study after RE-LY
- (2014) R. Nieuwlaat et al. EUROPEAN HEART JOURNAL
- Continuation of Dabigatran Therapy in “Real-World” Practice in Hong Kong
- (2014) Mei Han Ho et al. PLoS One
- When the Rubber Meets the Road: Adherence and Persistence with Non–Vitamin K Antagonist Oral Anticoagulants and Old Oral Anticoagulants in the Real World—A Problem or A Myth ?
- (2014) Deepa Suryanarayan et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Dabigatran etexilate for secondary stroke prevention: the first year experience from a multicenter short-term registry
- (2014) Georgios Tsivgoulis et al. Therapeutic Advances in Neurological Disorders
- Review of Challenges in Optimizing Oral Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
- (2013) Maria M. Fernandez et al. American Journal of Cardiovascular Drugs
- Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
- (2013) James V. Freeman et al. ANNALS OF INTERNAL MEDICINE
- The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study
- (2013) Stuart J. Connolly et al. CIRCULATION
- Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin
- (2013) Martin Zalesak et al.
- EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary†
- (2013) Hein Heidbuchel et al. EUROPEAN HEART JOURNAL
- A single centre experience of the efficacy and safety of dabigatran etexilate used for stroke prevention in atrial fibrillation
- (2013) Lok Bin Yap et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation
- (2013) Amanda R. Harrington et al. STROKE
- How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch
- (2012) S. Schulman et al. BLOOD
- Antithrombotic Therapy in Patients With Chronic Kidney Disease
- (2012) Davide Capodanno et al. CIRCULATION
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPACE
- Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemo
- (2012) W. AGENO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation
- (2010) Margaret C. Fang et al.
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Atrial Fibrillation in Congestive Heart Failure
- (2010) Steven A. Lubitz et al. Heart Failure Clinics
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects
- (2009) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started